Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2008
09/18/2008US20080226634 Tes7 and antibodies that bind thereto
09/18/2008US20080226633 Compositions and methods for the therapy and diagnosis of ovarian cancer
09/18/2008US20080226632 Cell growth factor specific immunoglobulin for treatment and prevention of cell proliferative and skin disorders
09/18/2008US20080226630 Recombinant antibodies for treatment of respiratory syncytial virus infections
09/18/2008US20080226628 CDR-Grafted Anti-Tissue Factor Antibodies and Methods of Use Thereof
09/18/2008US20080226621 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
09/18/2008US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells
09/18/2008US20080226617 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders
09/18/2008US20080226615 Vectors having both isoforms of beta-hexosaminidase and uses of the same
09/18/2008US20080226610 Expression vector comprising nucleotide sequences coding syncytium-inducing polypeptide for use in targeting tumor cells for destruction; antitumor agents
09/18/2008US20080226607 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells
09/18/2008US20080226606 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells
09/18/2008US20080226605 Methods and Compositions Facilitating Entry of Compounds Into Cells
09/18/2008US20080226603 Prebiotic
09/18/2008US20080226602 RNA viral vector for use in targeting tumor cell for destruction; antitumor agents and gene therapy
09/18/2008US20080226600 Adeno-associated viruses and uses thereof
09/18/2008US20080226599 Methods of treatment involving p21/CIP1
09/18/2008US20080226598 Dendritc specific RNA viral plasmid comprising nucleotide sequences coding tumor associated for use in developing cancer vaccine; genetic vaccines
09/18/2008US20080226597 Viricidal protein for prevention and treatment of hepatitis infection
09/18/2008US20080226586 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders
09/18/2008US20080226560 Supplying cargo compound into cancer cells; cargo compound may be nucleic acids, Dna, Rna
09/18/2008US20080226558 Mesoderm and definitive endoderm cell populations
09/18/2008US20080226556 Using macrophages;milk fat globulins; epidermal growth factor mutants
09/18/2008US20080226553 Transfection of stem cells; cell proliferation
09/18/2008DE202008000954U1 Femtosekunden-Lasersystem zur Materialbearbeitung Femtosecond laser system for material processing
09/18/2008CA2821430A1 Dominant gene suppression transgenes and methods of using same
09/18/2008CA2703136A1 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer
09/18/2008CA2688121A1 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts
09/18/2008CA2681301A1 Flavonoid-3',5'-hydroxylase gene of commelina communis
09/18/2008CA2681170A1 Methods for producing active scfv antibodies and libraries therefor
09/18/2008CA2681169A1 Mutagenized tobacco plant as seed culture for the production of oil for energetic, industrial and alimentary uses
09/18/2008CA2680799A1 Dominant gene suppression transgenes and methods of using same
09/18/2008CA2680794A1 Trichoderma reesei .alpha.-amylase enhances saccharification of corn starch
09/18/2008CA2680759A1 Kunitz-type recombinant inhibitor
09/18/2008CA2680742A1 Improving cold- and salt-tolerant performance of plants with transcription factor gene snac2 from rice
09/18/2008CA2680656A1 Endoglucanase ppce and cellulase preparation containing the same
09/18/2008CA2680613A1 Methods for generation of antibodies
09/18/2008CA2680600A1 Li-rnai involved li suppression in cancer immunotherapy
09/18/2008CA2680558A1 Clinical sample preparation on a microfluidic platform
09/18/2008CA2680549A1 Prognostic, diagnostic, and cancer therapeutic uses of fanci and fanci modulating agents
09/18/2008CA2680401A1 Somatotransgenic bioimaging
09/18/2008CA2680273A1 Thermostable asparaginases
09/18/2008CA2680158A1 Alkaliphilic bacillus species .alpha.-amylase variants, compositions comprising .alpha.-amylase variants, and methods of use
09/18/2008CA2679972A1 Method of expression of foreign gene in plant induced by chemical substance
09/18/2008CA2679696A1 He4 monoclonal antibodies and methods for their use
09/18/2008CA2679647A1 Peptide-complement conjugates
09/18/2008CA2679571A1 Use of nematode chitinase genes to control plant parasitic nematodes
09/18/2008CA2679497A1 Diagnostic and therapeutic aspects of sparc promoter hypermethylation in colon cancer
09/18/2008CA2678721A1 Reoviruses having modified sequences
09/18/2008CA2670702A1 Transfection in electronically driven continuous flow
09/18/2008CA2666323A1 Maize event dp-098140-6 and compositions and methods for the identification and/or detection thereof
09/18/2008CA2658612A1 Antibodies directed to .alpha.v.beta.6 and uses thereof
09/17/2008EP1970707A1 Method for detection of virulent strain of influenza type-a virus
09/17/2008EP1970452A1 Method of examining zinc-deficient taste disturbance
09/17/2008EP1970449A1 Attenuated salmonella SPI2 mutants as antigen carriers
09/17/2008EP1970448A1 Human artificial chromosome containting human antibody lambda light chain and non-human animal containting the human artificial chromosome capable of genetic transmission
09/17/2008EP1970447A1 Barley row type gene and use thereof
09/17/2008EP1970446A1 Nuclear reprogramming factor
09/17/2008EP1970444A1 Method for production of antigen-specific hybridoma using artificial lymph node with good efficiency
09/17/2008EP1970442A1 Transgenic high tryptophan plants
09/17/2008EP1970386A2 Hybrid immunoglobulins
09/17/2008EP1970385A2 Tetravalent anti-CD20 and/or anti-CD23 antibodies
09/17/2008EP1970383A1 Compounds and methods for modulating nonclassical cadherin-mediated functions
09/17/2008EP1970382A1 Activated collagen scaffold materials and their special fused active restoration factors
09/17/2008EP1970380A1 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof
09/17/2008EP1970078A1 Composition inhibiting the expression of target gene in eyeball and remedy for disease in eyeball
09/17/2008EP1970075A1 THERAPEUTIC AGENT FOR NEUROBLASTOMA TARGETING ARID3b
09/17/2008EP1970072A1 Use of GLP-2 peptides for the treatment of hyperparathyroidism
09/17/2008EP1970058A1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
09/17/2008EP1969367A2 Assay for parkinson's disease therapeutics and enzymatically active parkin preparations useful therein
09/17/2008EP1969165A1 Methods for generating and screening fusion protein libraries and uses thereof
09/17/2008EP1969146A1 Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids and utilities
09/17/2008EP1969138A1 Method for detecting the presence or absence of a target cell in a sample
09/17/2008EP1969127A2 Method of producing biologically active vitamin k dependent proteins by recombinant methods
09/17/2008EP1969126A1 Method of detecting and reducing boar taint using nuclear receptors
09/17/2008EP1969125A2 Micrornas that regulate muscle cell proliferation and differentiation
09/17/2008EP1969124A1 A rice gene, gs3, exerting primary control over grain length and grain weight
09/17/2008EP1969123A1 Novel enzymes
09/17/2008EP1969003A1 Novel neurotrophic factor protein and uses thereof
09/17/2008EP1969000A2 Cell penetrating peptides for intracellular delivery of molecules
09/17/2008EP1968994A2 Synthetic genomes
09/17/2008EP1968648A2 Diagnostic system for the detection and diagnosis of skin cancer
09/17/2008EP1968630A2 Multivalent pcv2 immunogenic compositions and methods of producing such compositions
09/17/2008EP1968372A2 Promoter sequence obtained from rice and methods of use
09/17/2008EP1859046A4 Expression vector for animal cell comprising at least one copy of mar dna sequences at the 3'terminal of transcription termination region of a gene and method for the expression of foreign gene using the vector
09/17/2008EP1773110A4 Nucleic acids encoding anthelmintic agents and plants made therefrom
09/17/2008EP1756278B1 Method of improving t cell receptors
09/17/2008EP1641925B1 Food additive comprising pseudomonas non-maltogenic exoamylase variants
09/17/2008EP1582587B1 Cold-induced expression vector
09/17/2008EP1563071B1 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
09/17/2008EP1544292B1 Glucose dehydrogenase
09/17/2008EP1526840B1 Nanoparticles for dna administration to a target organ
09/17/2008EP1509543B1 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
09/17/2008EP1491888B1 Microarray comprising gel having biosubstance fixed thereto as well as manufacture and use thereof
09/17/2008EP1476582B1 Nucleotide sequence coding for a tolc containing a heterologous amino acid sequence
09/17/2008EP1476563B1 Method for the recombination of genetic elements
09/17/2008EP1458486B1 Array plates and method for constructing array plates
09/17/2008EP1414947B1 Multipotent stem cells from peripheral tissues and uses thereof
09/17/2008EP1409692B1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine
09/17/2008EP1407038B1 A thermostable isomerase and use thereof, in particular for producing tagatose